{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:34:55Z","timestamp":1791153295948,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":3254,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/mi.2012.83","type":"journal-article","created":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T08:27:14Z","timestamp":1347438434000},"page":"393-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice"],"prefix":"10.1016","volume":"6","author":[{"given":"S","family":"Domingos-Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Decrausaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Derr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bobst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J T","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Jichlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nardelli-Haefliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mi.2012.83_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55,","author":"Bosch","year":"2002","journal-title":"J. Clin. Pathol"},{"issue":"Suppl 10","key":"10.1038\/mi.2012.83_bib2","doi-asserted-by":"crossref","first-page":"K53","DOI":"10.1016\/j.vaccine.2008.06.002","article-title":"An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results","volume":"26","author":"Schiller","year":"2008","journal-title":"Vaccine"},{"key":"10.1038\/mi.2012.83_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.arcmed.2009.07.003","article-title":"The therapeutic vaccine: is it feasible?","volume":"40,","author":"Gissmann","year":"2009","journal-title":"Arch. Med. Res"},{"key":"10.1038\/mi.2012.83_bib4","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/eji.200323919","article-title":"Role of Toll-like receptors in costimulating cytotoxic T cell responses","volume":"33,","author":"Schwarz","year":"2003","journal-title":"Eur. J. Immunol"},{"key":"10.1038\/mi.2012.83_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.173.1.531","article-title":"TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells","volume":"173,","author":"Matsushima","year":"2004","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2012.83_bib6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4049\/jimmunol.174.2.992","article-title":"Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C)","volume":"174,","author":"Schaefer","year":"2005","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2012.83_bib7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354,","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med"},{"key":"10.1038\/mi.2012.83_bib8","doi-asserted-by":"crossref","first-page":"976024","DOI":"10.1155\/2010\/976024","article-title":"Pattern recognition via the Toll-like receptor system in the human female genital tract","volume":"2010,","author":"Nasu","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1038\/mi.2012.83_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0897.2006.00381.x","article-title":"Effect of Toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse","volume":"55,","author":"Soboll","year":"2006","journal-title":"Am. J. Reprod. Immunol"},{"key":"10.1038\/mi.2012.83_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jri.2006.09.001","article-title":"MHC expression and chemokine production in the murine vagina following intra-vaginal administration of ligands to toll-like receptors 3, 7 and 9","volume":"73,","author":"Nurkkala","year":"2007","journal-title":"J. Reprod. Immunol"},{"key":"10.1038\/mi.2012.83_bib11","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/ijc.24949","article-title":"Induction of Human papillomavirus oncogene-specific CD8 T cell effector responses in the genital mucosa of vaccinated mice","volume":"126,","author":"Decrausaz","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1038\/mi.2012.83_bib12","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ijc.25561","article-title":"A novel mucosal orthotopic murine model of Human papillomavrius-associated genital cancers","volume":"128,","author":"Decrausaz","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1038\/mi.2012.83_bib13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ijc.25973","article-title":"Parenteral but not mucosal immunization is able to induce regression of human papillomavirus associated genital tumors","volume":"129,","author":"Decrausaz","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1038\/mi.2012.83_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301,","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"10.1038\/mi.2012.83_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441,","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"10.1038\/mi.2012.83_bib16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437,","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"10.1038\/mi.2012.83_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/09680519040100060501","article-title":"Mechanisms of TLR9 activation","volume":"10,","author":"Latz","year":"2004","journal-title":"J. Endotoxin. Res"},{"key":"10.1038\/mi.2012.83_bib18","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition","volume":"98,","author":"Bauer","year":"2001","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1038\/mi.2012.83_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/CVI.00392-07","article-title":"Monitoring of vaccine-specific gamma interferon inductionin in genital mucosa of mice by real-time reverse-transcription-PCR","volume":"5,","author":"Revaz","year":"2008","journal-title":"Clin. Vacc. Immunol"},{"key":"10.1038\/mi.2012.83_bib20","doi-asserted-by":"crossref","first-page":"e20448","DOI":"10.1371\/journal.pone.0020448","article-title":"Unraveling molecular signatures of immunostimulatory adjuvants in the female genital tract through systems biology","volume":"6,","author":"Lindqvist","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/mi.2012.83_bib21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"10,","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol"},{"key":"10.1038\/mi.2012.83_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000254948","article-title":"Intranasal administration of CpG induces a rapid and transient cytokine response followed by dendritic and natural killer cell activation and recruitment in the mouse lung","volume":"2,","author":"Pesce","year":"2010","journal-title":"J. Innate Immun"},{"key":"10.1038\/mi.2012.83_bib23","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI40817","article-title":"Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population","volume":"120,","author":"Antonelli","year":"2010","journal-title":"J. Clin. Invest"},{"key":"10.1038\/mi.2012.83_bib24","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1128\/JVI.77.16.8948-8956.2003","article-title":"Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2","volume":"77,","author":"Ashkar","year":"2003","journal-title":"J. Virol"},{"key":"10.1038\/mi.2012.83_bib25","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-08-0526","article-title":"CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans","volume":"14,","author":"Haining","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"10.1038\/mi.2012.83_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6,","author":"Borden","year":"2007","journal-title":"Nat. Rev. Drug. Discov"},{"key":"10.1038\/mi.2012.83_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4049\/jimmunol.180.2.683","article-title":"Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses","volume":"180,","author":"Kumar","year":"2008","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2012.83_bib28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.4049\/jimmunol.178.2.1164","article-title":"MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists","volume":"178,","author":"Bagchi","year":"2007","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2012.83_bib29","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1128\/JVI.01099-06","article-title":"Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection","volume":"80,","author":"Herbst-Kralovetz","year":"2006","journal-title":"J. Virol"},{"key":"10.1038\/mi.2012.83_bib30","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.4049\/jimmunol.0803044","article-title":"Bacterial DNA activates endothelial cells and promotes neutrophil adherence through TLR9 signaling","volume":"182,","author":"El Kebir","year":"2009","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2012.83_bib31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-0897.2009.00704.x","article-title":"Two different homing pathways involving integrin beta7 and E-selectin significantly influence trafficking of CD4 cells to the genital tract following chlamydia muridarum infection","volume":"61,","author":"Kelly","year":"2009","journal-title":"Am. J. Reprod. Immunol"},{"key":"10.1038\/mi.2012.83_bib32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-0897.2005.00262.x","article-title":"Homing in on the cellular immune response to HSV-2 in humans","volume":"53,","author":"Koelle","year":"2005","journal-title":"Am. J. Reprod. Immunol"},{"key":"10.1038\/mi.2012.83_bib33","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1128\/IAI.68.10.5587-5594.2000","article-title":"Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo","volume":"68,","author":"Hawkins","year":"2000","journal-title":"Infect. Immun"},{"key":"10.1038\/mi.2012.83_bib34","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1182\/blood-2011-07-343566","article-title":"Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow","volume":"118,","author":"Zarbock","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mi.2012.83_bib35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/mi.2010.58","article-title":"CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa","volume":"4,","author":"Olive","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1038\/mi.2012.83_bib36","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.4049\/jimmunol.161.6.3042","article-title":"Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA","volume":"161,","author":"Jakob","year":"1998","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2012.83_bib37","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.4049\/jimmunol.179.4.2493","article-title":"Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself","volume":"179,","author":"Li","year":"2007","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2012.83_bib38","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.4049\/jimmunol.169.7.3892","article-title":"Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model","volume":"169,","author":"Heckelsmiller","year":"2002","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2012.83_bib39","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.4049\/jimmunol.171.8.3941","article-title":"Intratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunity","volume":"171,","author":"Lonsdorf","year":"2003","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2012.83_bib40","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI200419762","article-title":"Induction of potent antitumor immunity by in situ targeting of intratumoral DCs","volume":"113,","author":"Furumoto","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1038\/mi.2012.83_bib41","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/jid.2008.59","article-title":"Topical CpG enhances the response of murine malignant melanoma to dacarbazine","volume":"128,","author":"Najar","year":"2008","journal-title":"J. Invest. Dermatol"},{"key":"10.1038\/mi.2012.83_bib42","doi-asserted-by":"crossref","first-page":"e10626","DOI":"10.1371\/journal.pone.0010626","article-title":"Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG","volume":"5,","author":"van den Boorn","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/mi.2012.83_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1753425909105581","article-title":"Class C CpG oligodeoxynucleotides as a single agent and in combination with radiotherapy efficiently delayed growth of subcutaneous B16F1 tumors","volume":"15,","author":"Cerkovnik","year":"2009","journal-title":"Innate Immunol"},{"key":"10.1038\/mi.2012.83_bib44","doi-asserted-by":"crossref","first-page":"e8368","DOI":"10.1371\/journal.pone.0008368","article-title":"Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice","volume":"4,","author":"Nierkens","year":"2009","journal-title":"PLoS One"},{"key":"10.1038\/mi.2012.83_bib45","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00262-011-1038-y","article-title":"Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN","volume":"60,","author":"Geary","year":"2011","journal-title":"Cancer Immunol., Immunother.: CII"},{"key":"10.1038\/mi.2012.83_bib46","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ijc.10084","article-title":"Influence of the mucosal epithelium microenvironment on langerhans cells: implications for the development of squanous intraepithelial lesions of the cervix","volume":"97,","author":"Giannini","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1038\/mi.2012.83_bib47","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1073\/pnas.0704672104","article-title":"Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens","volume":"104,","author":"Van der Burg","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1038\/mi.2012.83_bib48","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bjc.6605611","article-title":"Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia","volume":"102,","author":"Daayana","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1038\/mi.2012.83_bib49","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0264-410X(01)00292-4","article-title":"Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization","volume":"20,","author":"Glueck","year":"2001","journal-title":"Vaccine"}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mi201283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi201283","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922011990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922011990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi201283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:25:00Z","timestamp":1761830700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922011990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1933021922011990"],"URL":"https:\/\/doi.org\/10.1038\/mi.2012.83","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mi.2012.83","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/mi.2013.4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 \u00a9 Society for Mucosal Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}